Evidence-based·Updated November 19, 2026·How we grade evidence

Finasteride

Medication5-alpha reductase inhibitor (prescription)

Finasteride is an FDA-approved DHT blocker with good trial evidence for two uses: 1 mg (Propecia) slows male pattern hair loss and regrows some hair in men aged 18 to 41, and 5 mg (Proscar) eases BPH symptoms and roughly halves the risk of urinary retention and prostate surgery over 4 years. It did not help postmenopausal women with hair loss. In the first year of the trials, sexual side effects were reported by 3.8% of men on 1 mg (2.1% on placebo) and more often on 5 mg, and the labels list reports of sexual problems continuing after stopping, depression and suicidal thoughts; how often these happen, and whether finasteride causes the persistent symptoms, is not established.

Taking Finasteride with other supplements or medications?Check your whole list for interactions. Free, no account.

Prescription medication: not a dietary supplement

This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.

Quick decision guide

May help most

Men with male pattern hair loss on the crown or mid-scalp (Propecia 1 mg), and men with urinary symptoms from an enlarged prostate (Proscar 5 mg), whose prescriber recommends it

Common dosing range

Set by your prescriber: 1 mg once daily for hair loss (Propecia label); 5 mg once daily for BPH, alone or with doxazosin (Proscar label)

When to expect effects

Hair: usually 3 months or more of daily use before benefit is seen (Propecia label). BPH: symptoms improve over months, and the risk reductions were measured over 4 years

Watch out for

Contraindicated in women who are or may become pregnant, who should also not handle crushed or broken tablets. Can cause lower sex drive, erection and ejaculation problems; the labels list reports that these continued after stopping, plus depression and suicidal thoughts. It halves PSA, so tell anyone checking your PSA. Men on the 5 mg dose had more high-grade prostate cancer in a prevention trial (1.8% vs 1.1%)

What is it

Finasteride is a prescription tablet that blocks the enzyme that turns testosterone into dihydrotestosterone (DHT). It has two US labels at two doses, both now from Organon. The Propecia label (1 mg) approves it for male pattern hair loss (androgenetic alopecia) in men only; it is not indicated for women, and it has not been shown to work for receding temples. The Proscar label (5 mg) approves it for men with an enlarged prostate (benign prostatic hyperplasia, BPH) to improve urinary symptoms and lower the risk of sudden inability to urinate and of prostate surgery, and, together with the alpha-blocker doxazosin, to lower the risk of symptoms getting worse. Proscar is not approved to prevent prostate cancer. Generic finasteride is sold at both strengths.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if…

You are a man with mild to moderate male pattern hair loss and are willing to take it daily long term, since benefit reverses after stopping
You are a man with bothersome urinary symptoms from an enlarged prostate and your prescriber recommends it alone or with doxazosin
You have talked with your prescriber about sexual and mood side effects and know to report changes early

Probably skip if…

You are a woman who is or may become pregnant (contraindicated), or any woman or child, for whom neither label is indicated
You have had an allergic reaction to finasteride (contraindicated)
You want to prevent prostate cancer, which Proscar is not approved for
Your hair loss is mainly at the temples, where the Propecia label says benefit has not been established
You have a history of depression and have not discussed the reported mood effects with your prescriber

Evidence at a glance

male pattern hair loss (Propecia label)

Good Evidence
Effect
Moderate; about 12% to 16% more hairs in the treated area than placebo over 1 to 2 years
Best fit
Men aged 18 to 41 with mild to moderate hair loss on the crown or mid-scalp
Time
Improvement seen as early as 3 months (Propecia label); measured at 1 and 2 years in the cited paper

enlarged prostate: urinary retention and surgery (Proscar label)

Good Evidence
Effect
Large relative effect; about half the risk of surgery and urinary retention over 4 years
Best fit
Men with symptomatic BPH and an enlarged prostate
Time
Measured over 4 years

preventing BPH from getting worse, with doxazosin (Proscar label)

Good Evidence
Effect
Large; 66% lower risk of progression with the combination
Best fit
Men with BPH at risk of symptoms worsening
Time
Measured over a mean of 4.5 years

hair loss in postmenopausal women

Limited Evidence
Effect
No difference from placebo
Best fit
Not applicable
Time
Measured at 12 months

Evidence for 4 uses

AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.

male pattern hair loss (Propecia label)

Disease adjunct
Good Evidence

In two 1-year double-blind trials, 1,553 men aged 18 to 41 with mild to moderate hair loss on the crown took finasteride 1 mg or placebo daily, and 1,215 continued blinded for a second year. Hair count in a 1-inch circle of balding scalp (about 876 hairs at baseline) was 107 hairs higher than placebo at 1 year and 138 hairs higher at 2 years, while placebo users kept losing hair. Self-assessments, investigator ratings and photo reviews agreed. The Propecia label adds that in the 5-year extension, investigators rated 77% of men on finasteride as having more hair versus 15% on placebo, although only 23 men were still on placebo in year 5. One of the paper's authors worked for the manufacturer.

Effect size
Moderate; about 12% to 16% more hairs in the treated area than placebo over 1 to 2 years
Time to effect
Improvement seen as early as 3 months (Propecia label); measured at 1 and 2 years in the cited paper
Best fit
Men aged 18 to 41 with mild to moderate hair loss on the crown or mid-scalp
Less likely
Men with receding temples, where the Propecia label says benefit has not been established, or with complete hair loss; men older than 41 were not in these trials, and the label says efficacy in men 65 and older has not been established

Bottom line: Daily finasteride 1 mg slows male pattern hair loss and regrows some hair, for as long as it is taken.

enlarged prostate: urinary retention and surgery (Proscar label)

Disease adjunct
Good Evidence

In the 4-year double-blind PLESS trial, 3,040 men with moderate to severe urinary symptoms and an enlarged prostate took finasteride 5 mg or placebo daily. Prostate surgery was needed by 5% on finasteride versus 10% on placebo (55% lower risk), and acute urinary retention occurred in 3% versus 7% (57% lower risk). Among men who finished, symptom scores fell by 3.3 points versus 1.3 on placebo, urine flow improved and the prostate shrank.

Effect size
Large relative effect; about half the risk of surgery and urinary retention over 4 years
Time to effect
Measured over 4 years
Best fit
Men with symptomatic BPH and an enlarged prostate
Less likely
Men with urinary symptoms but a small prostate, or with other urinary conditions

Bottom line: Daily finasteride 5 mg roughly halved the need for prostate surgery and urinary retention over 4 years.

preventing BPH from getting worse, with doxazosin (Proscar label)

Disease adjunct
Good Evidence

In the double-blind MTOPS trial, 3,047 men with BPH were followed for a mean of 4.5 years on placebo, doxazosin, finasteride or both. Compared with placebo, the risk of overall clinical progression (a rise of at least 4 points in symptom score, acute urinary retention, incontinence, kidney insufficiency or repeated urinary infections) fell by 39% with doxazosin, 34% with finasteride and 66% with the combination, which beat either drug alone. Finasteride and the combination, but not doxazosin alone, lowered the risk of urinary retention and invasive treatment.

Effect size
Large; 66% lower risk of progression with the combination
Time to effect
Measured over a mean of 4.5 years
Best fit
Men with BPH at risk of symptoms worsening
Less likely
Men who cannot tolerate the low blood pressure or dizziness an alpha-blocker can cause

Bottom line: Finasteride plus doxazosin prevented BPH from getting worse better than either drug alone.

hair loss in postmenopausal women

No benefit found
Limited Evidence

In a 1-year double-blind trial, 137 postmenopausal women aged 41 to 60 with androgenetic alopecia took finasteride 1 mg or placebo daily. Hair counts, self-assessments, investigator ratings, photo reviews and scalp biopsies showed no improvement compared with placebo; both groups lost hair. Propecia is not indicated for women, and it is contraindicated in women who are or may become pregnant.

Effect size
No difference from placebo
Time to effect
Measured at 12 months
Best fit
Not applicable
Less likely
Postmenopausal women with androgenetic alopecia

Bottom line: Finasteride 1 mg did not help hair loss in postmenopausal women.

How it works

Finasteride selectively blocks type II 5-alpha-reductase, the form of the enzyme found mainly in the prostate, seminal vesicles, hair follicles and liver, which makes about two-thirds of the body's DHT. The Propecia label says a 1 mg dose cuts blood DHT by 65% within 24 hours, while testosterone rises by about 15% but stays in the normal range. In balding scalp, lower DHT slows the shrinking of hair follicles; in the prostate, lower DHT shrinks the gland over months. The drug itself leaves the blood quickly (half-life about 6 hours in younger men and 8 hours in men 70 and older, Proscar label), and both labels give it once a day. Its effects reverse after stopping: the Propecia label says hair gained is lost within 12 months. Because DHT is needed for a male fetus to develop normally, the drug is contraindicated in pregnancy, and women who are or may be pregnant should not handle crushed or broken tablets. At the 5 mg dose it also roughly halves PSA, the blood test used to screen for prostate cancer, and the 1 mg dose lowers PSA too.

How to take it

1. Typical dose
Your prescriber sets the dose. Propecia label (hair loss): one 1 mg tablet once daily. Proscar label (BPH): one 5 mg tablet once daily, alone or in combination with doxazosin. The two strengths are not interchangeable for these uses.
2. Higher studied dose
The labeled doses are 1 mg daily (Propecia) and 5 mg daily (Proscar). The Propecia label says taking it more than once a day will not make it work faster or better.
3. Timing
Once daily, at any consistent time. The Propecia patient information says that if you forget a dose, do not take an extra tablet; take the next one as usual.
4. With food
With or without meals, according to both labels.
5. Split dosing
Not split. Women who are or may be pregnant should not handle crushed or broken tablets.
6. How long to try
Long term, as your prescriber decides. The Propecia label says daily use for 3 months or more is usually needed before benefit is seen, continued use is needed to keep it, and stopping reverses the effect within 12 months.

What to track

Lower sex drive, trouble with erections, less semen or other ejaculation changes; tell your prescriber, including if they continue after stopping
Low mood, loss of interest, or thoughts of self-harm or suicide (seek help promptly)
Breast lumps, pain, enlargement or nipple discharge
Your PSA result: tell whoever orders it that you take finasteride, since it lowers PSA
Hives, rash or swelling of the lips, tongue or face (allergic reaction)

Bottom line: One tablet a day at the dose your prescriber sets; give it at least 3 months for hair, keep tablets whole and away from pregnant women, and report sexual or mood changes early.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

Propecia (1 mg) trials, year 1: lower sex drive 1.8% vs 1.3% on placebo, erection problems 1.3% vs 0.7%, ejaculation disorder 1.2% vs 0.7%; in total 3.8% vs 2.1% reported one or more. The label says these resolved in the men who stopped because of them and in most of those who continued, and each fell to 0.3% or less by year 5Proscar (5 mg) PLESS trial, year 1: impotence 8.1% vs 3.7%, lower sex drive 6.4% vs 3.4%, less semen 3.7% vs 0.8%; in years 2 to 4 these did not differ from placeboLower semen volume: a median drop of 0.3 mL (11%) on 1 mg versus 0.2 mL (8%) on placebo; about 0.5 to 0.6 mL on 5 mg, which returned to normal after stopping (on average 84 weeks in one Proscar study)Breast enlargement or tenderness (0.5% and 0.4% versus 0.1% on placebo in the first year on 5 mg; not more common than placebo in the 1 mg hair-loss trials)Rash

Serious risks

  • Neither label has a boxed warning. Both list, from reports after approval, sexual problems that continued after stopping treatment (erectile dysfunction, libido and ejaculation disorders, and orgasm disorders), male infertility or poor semen quality that improved after stopping in some reports, testicular pain and blood in semen. Because these are voluntary reports, the labels say it is not always possible to reliably estimate how often they happen or to establish that the drug caused them. The Proscar label adds that lasting sexual problems were reported rarely in men taking it for BPH, that most of those men were older and took other medicines or had other conditions, and that finasteride's independent role is unknown.

  • Persistent symptoms after stopping: what research shows. In a case-control study at one academic center, men who reported lasting sexual symptoms after taking finasteride for hair loss had worse sexual function, higher depression scores and brain imaging patterns like those seen in depression, while their testosterone, DHT and markers of androgen action did not differ from those of past users without symptoms or men who never used it. The study could not show whether finasteride caused the symptoms or how common they are.

  • Depression and suicidal thoughts are listed on both labels from postmarketing reports. In an Ontario cohort of 93,197 men aged 66 or older starting finasteride or dutasteride for an enlarged prostate, suicide was not increased (hazard ratio 0.88), but self-harm was higher in the first 18 months (hazard ratio 1.88), not after, and new depression was higher (1.94 in the first 18 months, 1.22 after); the absolute increases were 17 and 237 per 100,000 patient-years. A study of the WHO's worldwide adverse-event reports found more suicidality and psychological reports with finasteride than expected, with the suicidality signal in patients younger than 45 and in those using it for hair loss, and no such signal in older patients with BPH; the authors said this may reflect heavier reporting, younger patients being more vulnerable, or both. Neither design proves cause.

  • Higher risk of high-grade prostate cancer: in the 7-year Prostate Cancer Prevention Trial, men 55 and older taking finasteride 5 mg had more Gleason 8 to 10 cancers (1.8% vs 1.1%). Finasteride also lowers PSA by about 50% on 5 mg, so any confirmed PSA rise while taking it should be checked, even if it is in the normal range. Male breast cancer has been reported; its link to finasteride is unknown.

Who should avoid it

Pregnancy & breastfeeding

Pregnancy: both labels say finasteride is contraindicated in women who are or may become pregnant, because blocking DHT may cause abnormal development of the external genitalia of a male fetus. Women who are or may become pregnant should not handle crushed or broken tablets; the coated tablets prevent contact during normal handling, and any contact with a broken tablet should be washed off with soap and water. Finasteride is found in small amounts in the semen of men taking it: the Proscar label estimates the highest amount at 50 to 100 times less than a dose that had no effect on DHT in men. Breastfeeding: neither product is indicated for women; the Propecia label says it is not known whether finasteride passes into human milk.

Choosing a product

What to look for on the label, and what to be skeptical of.

Look for…

Propecia (1 mg) or Proscar (5 mg), or generic finasteride at the strength your prescriber chose, from a licensed pharmacy
Film-coated tablets that stay whole; crushed or broken tablets should be kept away from women who are or may be pregnant
A patient information leaflet listing sexual side effects, including those reported to continue after stopping, and depression and suicidal thoughts
A note for your records that finasteride lowers PSA test results

Be skeptical of…

"DHT blocker" hair supplements (for example saw palmetto blends) presented as a proven replacement for finasteride
Claims that finasteride has no sexual side effects, or that sexual or mood effects always go away
Claims that finasteride prevents prostate cancer, which Proscar is not approved for
Online sellers offering finasteride without a prescription

Frequently asked questions

Can sexual side effects continue after stopping finasteride?⌄

Both labels list reports of sexual problems, including low libido and erection, ejaculation and orgasm problems, that continued after stopping. These come from voluntary reports, so how often it happens is not known, and the Proscar label says finasteride's own role in such reports is unknown. In the 1 mg trials, sexual side effects resolved in the men who stopped because of them and in most of those who continued. A small case-control study of men with lasting symptoms found no evidence of low androgen levels or ongoing enzyme blockade, but did find more depressive symptoms. Tell your prescriber about any change, during or after treatment.

Does finasteride cause depression?⌄

Depression and suicidal thoughts are listed on both labels from postmarketing reports. In a large Ontario study of men 66 and older, suicide was not increased, but self-harm and new depression were somewhat more common after starting these drugs. In a study of worldwide adverse-event reports, the signal for suicidality reports was seen in patients younger than 45 and in those using it for hair loss, not in older men with BPH. These studies cannot prove cause. If your mood drops or you have thoughts of self-harm, seek help promptly and contact your prescriber.

Can I take saw palmetto or other supplements with finasteride?⌄

Our interaction database has no supplement pairs for finasteride, and the labels list no clinically important drug interactions; tested medicines such as warfarin, digoxin and theophylline were not affected. Saw palmetto has not been tested together with finasteride in the studies we found. Ask your doctor or pharmacist before adding any "DHT blocker" product, so they know everything you take.

Can women take finasteride for hair loss?⌄

Propecia is not indicated for women. It is contraindicated in women who are or may become pregnant, and in a 1-year trial in 137 postmenopausal women it did not improve hair loss compared with placebo. Women who are or may be pregnant should not handle crushed or broken tablets.

Does finasteride affect the PSA test?⌄

Yes. The Proscar label says 5 mg lowers PSA by about 50% within 6 months, and 1 mg also lowered it in younger men. Tell whoever orders your PSA test that you take finasteride, because a confirmed rise while on it should be checked even if the number looks normal.

What is the difference between Propecia and Proscar?⌄

Both contain finasteride. Propecia is 1 mg once daily for male pattern hair loss. Proscar is 5 mg once daily for an enlarged prostate, alone or with doxazosin. Your prescriber chooses the product and strength for your condition.

References by claim

male pattern hair loss (Propecia label)

Kaufman et al., 1998 · PubMed (1998) link

hair loss in postmenopausal women

Price et al., 2000 · PubMed (2000) link

enlarged prostate: urinary retention and surgery (Proscar label)

McConnell et al., 1998 · PubMed (1998) link

preventing BPH from getting worse, with doxazosin (Proscar label)

McConnell et al., 2003 · PubMed (2003) link

Safety

Propecia (finasteride 1 mg) prescribing information · DailyMed (FDA label) link

Proscar (finasteride 5 mg) prescribing information · DailyMed (FDA label) link

Basaria et al., 2016 · PMC (2016) link

Welk et al., 2017 · PMC (2017) link

Nguyen et al., 2021 · PMC (2021) link

Track Finasteride with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora app.

Evidence-based·Updated Nov 19, 2026·Evidence current as of Nov 19, 2026·How we grade evidence

Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.